Abstract:The outbreak of COVID-19 pneumonia has accelerated the application of robots in the field of medical and health care, and the development of robots in China is still in "emerging stage". The study analyzes the relevant policies concerning medical and health robots in the United States, Japan, the European Union, and China in recent years, and finds that the differences in policy objectives are mainly manifested in four aspects: institution establishment, project development, platform construction, and legal ethics research. It is concluded that robots have strong adaptability and very broad application prospects in the medical and health field. In order to occupy the commanding heights of the "new generation of robots", the government needs to further strengthen the exploration of top-level design, market-oriented development, the establishment of big data platforms as well as regulations and ethics research, so as to achieve the vision of "smart medical" in the future.